Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Chlamydia: early-phase trial registry

2 of 6 indexed Chlamydia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Chlamydia: 6 US clinical trials tracked, 2 recruiting.

Chlamydia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 3 of these trials.

Enrollment posture brief

Registry condition chlamydia

OPEN 2 | RECR 33% | LATE 0 | EARLY 2 | RANK #2866 | SPON 3

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Chlamydia (this)33%
Open-enrollment share among volume-matched conditions near Chlamydia

Chlamydia lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chlamydia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chlamydia is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Chlamydia research.

    Northwestern University accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Chlamydia enrolment sits around 400 participants.

    Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Chlamydia research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Named interventions

Most-linked intervention names on Chlamydia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

2GETHER Behavioral
2 trials
Positive Affect Enhancement Behavioral
1 trials
Motivational interviewing and specimen self-collection Behavioral
1 trials
Love, Sex, & Choices Behavioral
1 trials
Existing Public Health Practice Behavioral
1 trials
Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas Diagnostic test
1 trials
all2GETHER Behavioral
1 trials

US sites by state

Facility locations filed on Chlamydia trials. A trial with sites in several states counts in each.

Illinois 3 trials
Michigan 1 trials
Massachusetts 1 trials
Hawaii 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chlamydia page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chlamydia condition card totals 6 registered trials; most-linked intervention 2GETHER; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.